輸入代號或公司名稱後按 Enter
4157

太景*-KY

-0.18 (-2.03%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
8.681,016成交張數39.45本益比6.03股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.030.21-0.21-258.7%-2.06%15.55%
2026Q1-0.020.07-0.14-138.5%-1.35%5.11%
2025Q40.280.062.0588.5%20.81%4.19%
2025Q3-0.02-0.25-0.14-209.6%-1.50%-18.36%
2025Q2-0.17-288.9%-0.33-1.23-1148.3%-12.18%-22.59%
2025Q1-0.03-0.07-0.23-208.2%-2.13%-5.11%
2024Q4-0.03-111.5%-0.05-0.25-235.1%-2.25%-3.51%
2024Q3-0.100.24-0.72-835.8%-6.30%16.97%
2024Q20.09800.0%0.330.6452.8%5.63%22.14%
2024Q1-0.010.25-0.06-61.3%-0.55%17.86%
2023Q40.260.191.862161.0%18.30%13.09%
2023Q3-0.01-150.0%-0.23-0.09-91.9%-0.92%-16.25%
2023Q20.01-0.200.1010.1%1.07%-13.68%
2023Q1-0.07-0.35-0.50-874.5%-5.34%-23.97%
2022Q4-0.16-0.33-1.12-2376.0%-10.98%-21.33%
2022Q30.02-0.370.1156.4%0.98%-21.47%
2022Q2-0.14-109.1%-0.58-1.03-3816.1%-8.81%-31.56%
2022Q1-0.051.09-0.33-342.9%-2.70%97.47%
2021Q4-0.201.08-1.40-9127.7%-10.56%91.47%
2021Q3-0.191.10-1.42-6011.2%-9.73%81.19%
2021Q21.531.1511.0088.4%114.18%76.73%
2021Q1-0.06-0.52-0.44-94.6%-10.28%-65.55%
2020Q4-0.18-0.56-1.30-1623.9%-26.42%-64.39%
2020Q3-0.14-0.66-0.99-2170.6%-16.86%-60.72%
2020Q2-0.14-255.6%-0.66-1.03-1372.9%-14.96%-54.16%
2020Q1-0.10-0.43-0.72-2173.3%-9.28%-34.65%
2019Q4-0.28-0.41-1.99-2923.7%-21.76%-30.99%
2019Q3-0.14-0.26-1.03-2141.1%-9.59%-17.43%
2019Q20.09-0.300.601457.1%5.50%-17.49%
2019Q1-0.08-0.52-0.54-1188.8%-5.00%-30.07%
2018Q4-0.13-0.48-0.96-2043.3%-8.40%-27.26%
2018Q3-0.18-0.53-1.25-2514.6%-9.94%-27.55%
2018Q2-0.13-109.6%-0.41-0.97-3048.3%-7.16%-20.38%
2018Q1-0.041.08-0.25-151.7%-1.80%76.67%
2017Q4-0.181.04-1.31-4986.8%-8.77%71.08%
2017Q3-0.061.14-0.44-537.1%-2.77%71.76%
2017Q21.361.119.76184.1%87.90%66.79%
2017Q1-0.08-0.30-0.55-453.1%-8.50%-29.07%
2016Q4-0.08-0.35-0.56-101.3%-7.95%
2016Q3-0.09-0.65-267.1%-8.55%